Results 111 to 120 of about 7,735 (207)
Approaches in evaluation of freeze-dried antibody conjugates [PDF]
, 2016 The presented experience was in freeze-drying of monoclonal antibody – rituximab, conjugated with three types of bifunctional chelating agents, p-SCN-Bn-DOTA, p-SCN-Bn-DTPA, and 1B4M-DTPA, and evaluation of possible changes in post-freeze-drying ...
Gjorgieva Ackova, Darinka +4 more
core
PharmaceuticalsThe present review provides a detailed and comprehensive discussion on antibody–drug conjugates (ADCs) as an evolving new modality in the current therapeutic landscape of malignant diseases.
Rositsa Mihaylova +3 more
doaj +1 more source
CD30-targeting immunoconjugates and bystander effects [PDF]
Nature Reviews Clinical Oncology, 2015 Shigeo, Masuda +3 more
openaire +2 more sources
Preclinical characterization of 3p-C-DEPA<sub>-NCS</sub> and 3p-C-DEPA<sub>-TFP</sub>-PEG<sub>4</sub> as potential Actinium-225 bifunctional chelators using DOTA<sub>-NCS</sub> and macropa<sub>-NCS</sub> as benchmarks. [PDF]
EJNMMI Radiopharm ChemPougoue Ketchemen J +8 more
europepmc +1 more source
Development of Optimized Exatecan-Based Immunoconjugates with Potent Antitumor Efficacy in HER2-Positive Breast Cancer. [PDF]
J Med ChemAuvert E +15 more
europepmc +1 more source